AbbVie Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (108)

Latest Posts

About This Stock More About This Stock
E Portfolio Review - June 4, 2018
Article By: Ingrid Hendershot
Monday, June 4, 2018 7:12 AM EDT
Here is a roundup covering the latest news on the stocks in our portfolio. As well as plans to add two more stocks.
In this article: ABBV, ESRX, CI, CAKE, NKE, CNI, THO, FB
Trump Announces Plan To Reign In Drug Prices And Pharma Stocks Rally
Article By: Zacks Investment Research
Sunday, May 13, 2018 11:37 AM EDT
President Trump unveiled his plan to control US drug prices. Stock prices of the biggest drug companies briefly declined, only to reverse course and ended the day broadly higher. The reason? The plan doesn’t seem to be “taking them on” at all.
In this article: LLY, MRK, AMGN, EXEL, ABBV
The 10 Best Dividend Aristocrat Stocks Today
Article By: SureDividend
Thursday, May 10, 2018 5:44 PM EDT
Dividend growth stocks are typically viewed as safe, “widow-and-orphan” stocks that should be held for steady dividend income instead of high share price appreciation. Here are 10 best dividend aristocrat stocks.
In this article: BEN, CAH, FRT, LEG, PPG, T, XOM, ABBV, WBA, SPGI
Pharma Stock Roundup: Mixed Q1 For MRK, PFE, FDA Nod For Kymriah's 2nd Indication
Article By: Zacks Investment Research
Friday, May 4, 2018 8:15 PM EDT
First-quarter results of pharma bigwigs like Pfizer, Merck and Allergan stole the limelight this week. Other than that, Novartis gained FDA approval for the second indication of its CAR-T therapy, Kymriah.
In this article: AGN, JNJ, MRK, NVS, PFE, UTHR, ABBV
2018 Biotech Sector Watch On Earnings: ABBV, ALXN, BMY
Article By: Rod Raynovich
Thursday, April 26, 2018 6:00 PM EDT
Abbvie (ABBV) is back on track. Alexion (ALXN) stock soared 14.6%. Bristol Myers-Squibb (BMY) raised its full year earnings forecast.
In this article: BMY, ALXN, ABBV Also: IBB, CELG, XBI, EDIT, CRSP


Latest Tweets for $ABBV

No tweets yet!


AbbVie Inc. Increases Humira Prices, Receives FDA Approval For New Drug
Bruce Powers 1/23/2017 6:21:09 PM

Excited to hear the #FDA approved #IMBRUVICA. Should bode very well for $ABBV. And I think it's 8% price hike of #Humira is reasonable (though I realize those taking the drug may disagree).

1 to 1 of 1 comments